A Different Molecular Pattern of Beta-thalassemia Mutations in Northeast Brazil
Overview
Authors
Affiliations
The main hereditary hemoglobin (Hb) disorders of clinical significance in Brazil are sickle cell disease and beta-thalassemia (thal). The sickle gene was introduced by the slave trade, whereas beta-thal was introduced later, due to a massive immigration (mostly by Italians) between 1870 and 1953, mainly to the southeast region of Brazil. Molecular studies performed in the southeast of the country showed a marked prevalence of the nonsense mutation at codon 39 (C --> T) (47-54%), leading to severe forms of beta0-thal. However, the northeast region of the country has a different demographic history, characterized by the absence of the massive Italian immigration. Owing to this and since the majority of cases of beta-thal in Pernambuco, a state located in the northeast of the country, have mild or intermediate clinical and laboratory features, we would predict a different spectrum of beta-thal mutations in this region. We examined 60 unrelated patients (86 beta-thal chromosomes) under regular clinical follow-up in Pernambuco: 6 were regularly transfused beta-thal major subjects, 20 had beta-thal intermedia, 20 had Hb S/beta-thal and 14 were beta-thal trait individuals. The following mutations were found: IVS-I-6 (T --> C) 62.8%, IVS-I-1 (G -->A) 15.1%, IVS-I-5 (G --> C) 9.3%, IVS-I-110 (G --> A) 8.2%, codon 39 (C --> T) 3.5%, and codon 30 (AGG --> AGC) 1.1%. These data show different patterns of beta-thal mutations in two regions of Brazil, demonstrating a thus far unrevealed heterogeneity of the disease in the country.
Sickle cell disease and increased adverse maternal and perinatal outcomes in different genotypes.
Figueira C, Guida J, Surita F, Antolini-Tavares A, Saad S, Costa F Hematol Transfus Cell Ther. 2024; 46 Suppl 5:S189-S196.
PMID: 38494406 PMC: 11670601. DOI: 10.1016/j.htct.2024.02.013.
Oliveira E, Rolim Belisario A, Silva N, Rezende P, Muniz M, Oliveira L Hematol Transfus Cell Ther. 2024; 46(2):167-175.
PMID: 38182466 PMC: 11150486. DOI: 10.1016/j.htct.2023.11.002.
Torres F, Bernardo V, Silva D, Okumura J, Bonini-Domingos C Hematol Transfus Cell Ther. 2020; 44(2):156-162.
PMID: 33309469 PMC: 9123579. DOI: 10.1016/j.htct.2020.09.147.
Belisario A, Carneiro-Proietti A, Sabino E, Araujo A, Loureiro P, Maximo C Hemoglobin. 2020; 44(1):1-9.
PMID: 32172616 PMC: 7225056. DOI: 10.1080/03630269.2020.1731530.
Use of an automated pyrosequencing technique for confirmation of sickle cell disease.
de Martino C, Alencar C, Loureiro P, Barbara de Freitas Carneiro-Proietti A, Maximo C, Mota R PLoS One. 2019; 14(12):e0216020.
PMID: 31830127 PMC: 6907837. DOI: 10.1371/journal.pone.0216020.